Evaluation of algorithms using automated health plan data to identify breast cancer recurrences.


Journal

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
ISSN: 1538-7755
Titre abrégé: Cancer Epidemiol Biomarkers Prev
Pays: United States
ID NLM: 9200608

Informations de publication

Date de publication:
13 Dec 2023
Historique:
accepted: 11 12 2023
received: 18 07 2023
revised: 20 11 2023
medline: 13 12 2023
pubmed: 13 12 2023
entrez: 13 12 2023
Statut: aheadofprint

Résumé

We updated algorithms to identify breast cancer recurrences from administrative data, extending previously developed methods. In this validation study, we evaluated pairs of breast cancer recurrence algorithms (vs. individual algorithms) to identify recurrences. We generated algorithm combinations that categorized discordant algorithm results as no recurrence (High Specificity and PPV Combination) or recurrence (High Sensitivity Combination). We compared individual and combined algorithm results to manually abstracted recurrence outcomes from a sample of 600 people with incident stage I-IIIA breast cancer diagnosed between 2004-2015. We used Cox regression to evaluate risk factors associated with age- and stage-adjusted recurrence rates using different recurrence definitions, weighted by inverse sampling probabilities. Among 600 people, we identified 117 recurrences using the High Specificity and PPV Combination, 505 using the High Sensitivity Combination, and 118 using manual abstraction. The High Specificity and PPV Combination had good specificity (98%, 95%CI: 97-99%) and PPV (72%, 95%CI: 63-80%) but modest sensitivity (64%, 95%CI: 44-80%). The High Sensitivity Combination had good sensitivity (80%, 95%CI: 49-94%) and specificity (83%, 95%CI: 80-86%) but low PPV (29%, 95%CI: 25-34%). Recurrence rates using combined algorithms were similar in magnitude for most risk factors. By combining algorithms, we identified breast cancer recurrences with greater positive predictive value than individual algorithms, without additional review of discordant records. Researchers should consider tradeoffs between accuracy and manual chart abstraction resources when using previously developed algorithms. We provided guidance for future studies that use breast cancer recurrence algorithms with or without supplemental manual chart abstraction.

Sections du résumé

BACKGROUND BACKGROUND
We updated algorithms to identify breast cancer recurrences from administrative data, extending previously developed methods.
METHODS METHODS
In this validation study, we evaluated pairs of breast cancer recurrence algorithms (vs. individual algorithms) to identify recurrences. We generated algorithm combinations that categorized discordant algorithm results as no recurrence (High Specificity and PPV Combination) or recurrence (High Sensitivity Combination). We compared individual and combined algorithm results to manually abstracted recurrence outcomes from a sample of 600 people with incident stage I-IIIA breast cancer diagnosed between 2004-2015. We used Cox regression to evaluate risk factors associated with age- and stage-adjusted recurrence rates using different recurrence definitions, weighted by inverse sampling probabilities.
RESULTS RESULTS
Among 600 people, we identified 117 recurrences using the High Specificity and PPV Combination, 505 using the High Sensitivity Combination, and 118 using manual abstraction. The High Specificity and PPV Combination had good specificity (98%, 95%CI: 97-99%) and PPV (72%, 95%CI: 63-80%) but modest sensitivity (64%, 95%CI: 44-80%). The High Sensitivity Combination had good sensitivity (80%, 95%CI: 49-94%) and specificity (83%, 95%CI: 80-86%) but low PPV (29%, 95%CI: 25-34%). Recurrence rates using combined algorithms were similar in magnitude for most risk factors.
CONCLUSIONS CONCLUSIONS
By combining algorithms, we identified breast cancer recurrences with greater positive predictive value than individual algorithms, without additional review of discordant records.
IMPACT CONCLUSIONS
Researchers should consider tradeoffs between accuracy and manual chart abstraction resources when using previously developed algorithms. We provided guidance for future studies that use breast cancer recurrence algorithms with or without supplemental manual chart abstraction.

Identifiants

pubmed: 38088912
pii: 731718
doi: 10.1158/1055-9965.EPI-23-0782
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Erin J Aiello Bowles (EJ)

Kaiser Permanente Washington Health Research Institute, Seattle, Washington, United States.

Candyce H Kroenke (CH)

Kaiser Permanente, Oakland, CA, United States.

Jessica Chubak (J)

Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States.

Jenna Bhimani (J)

Memorial Sloan Kettering Cancer Center, United States.

Kelli O'Connell (K)

Memorial Sloan Kettering Cancer Center, New York, New York, United States.

Susan Brandzel (S)

Kaiser Permanente Washington Health Research Institute, Seattle, Washington, United States.

Emily Valice (E)

Kaiser Permanente, Oakland, CA, United States.

Rachael Doud (R)

Kaiser Permanente Washington Health Research Institute, Seattle, Washington, United States.

Mary Kay Theis (MK)

Kaiser Permanente Washington Health Research Institute, Seattle, Washington, United States.

Janise M Roh (JM)

Kaiser Permanente, Oakland, CA, United States.

Narre Heon (N)

Memorial Sloan Kettering Cancer Center, New York, New York, United States.

Sonia Persaud (S)

Memorial Sloan Kettering Cancer Center, New York, New York, United States.

Jennifer J Griggs (JJ)

University of Michigan-Ann Arbor, Ann Arbor, MI, United States.

Elisa V Bandera (EV)

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States.

Lawrence H Kushi (LH)

Kaiser Permanente, Oakland, CA, United States.

Elizabeth D Kantor (ED)

Memorial Sloan Kettering Cancer Center, New York, NY, United States.

Classifications MeSH